[Advance in biomarkers of lung cancer in diagnosis and targeted therapy].
Zhang
Jing
J
Liang
Zhi-yong
ZY
Zeng
Xuan
X
Liu
Tong-hua
TH
D017766:Acid Anhydride Hydrolases / Q000378:metabolism; D017209:Apoptosis; D014408:Biomarkers, Tumor / Q000378:metabolism*; D020169:Caspases / Q000378:metabolism; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002872:Chromosome Deletion; D016503:Drug Delivery Systems; D066246:ErbB Receptors / Q000378:metabolism; D058851:GPI-Linked Proteins / Q000378:metabolism; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000378:metabolism; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D009367:Neoplasm Staging; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D000099170:Bis(5'-adenosyl)triphosphatase
D017766:Acid Anhydride Hydrolases; D014408:Biomarkers, Tumor; D020169:Caspases; D015815:Cell Adhesion Molecules; D066246:ErbB Receptors; D058851:GPI-Linked Proteins; D006821:Hyaluronoglucosaminidase; D009363:Neoplasm Proteins; D042461:Vascular Endothelial Growth Factor A; D000099170:Bis(5'-adenosyl)triphosphatase; C512478:EGFR protein, human; C473096:Hyal2 protein, human